UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 222

Sortiert nach

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2017-07, Vol.18 (7), p.904-916

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2630-2637

2009

Link zum Volltext

Verfügbarkeit prüfen

Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial

BMC cancer, 2017-09, Vol.17 (1), p.632-632, Article 632

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved Overall Survival in Postmenopausal Women With Early Breast Cancer After Anastrozole Initiated After Treatment With Tamoxifen Compared With Continued Tamoxifen: The ARNO 95 Study

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2664-2670

2007

Link zum Volltext

Verfügbarkeit prüfen

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1940-1949

2006

Link zum Volltext

Verfügbarkeit prüfen

Innovative Diagnostik zur Therapieoptimierung

Gynäkologe (Berlin), 2021-03, Vol.54 (3), p.154-155

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined Surgical and Hormone Therapy for Endometriosis is the Most Effective Treatment: Prospective, Randomized, Controlled Trial

Journal of minimally invasive gynecology, 2013-07, Vol.20 (4), p.473-481

2013

Link zum Volltext

Verfügbarkeit prüfen

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

BMC cancer, 2010-08, Vol.10 (1), p.412-412, Article 412

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

Oncogene, 2005-02, Vol.24 (6), p.1053-1065

2005

Link zum Volltext

Verfügbarkeit prüfen

Immuntherapie in der gynäkologischen Onkologie

Die Gynäkologie, 2023-04, Vol.56 (4), p.233-234

2023

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma

European journal of obstetrics & gynecology and reproductive biology, 2012-01, Vol.160 (1), p.74-78

2012

Link zum Volltext

Verfügbarkeit prüfen

One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group

Virchows Archiv : an international journal of pathology, 2009-02, Vol.454 (2), p.203-210

2009

Link zum Volltext

Verfügbarkeit prüfen

DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples

PloS one, 2012-06, Vol.7 (6), p.e39014-e39014

2012

Link zum Volltext

Verfügbarkeit prüfen

Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review

Fertility and sterility, 2011-03, Vol.95 (3), p.1119.e5-1119.e8

2011

Link zum Volltext

Verfügbarkeit prüfen

Integrative Medizin in der gynäkologischen Onkologie

Gynäkologe (Berlin), 2017, Vol.50 (1), p.8-8

2017

Link zum Volltext

Verfügbarkeit prüfen

Organ-preserving management of ovarian pregnancies by laparoscopic approach

Fertility and sterility, 2011-06, Vol.95 (8), p.2467-2470.e2

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of the Tumor Suppressor Gene Maspin in Human Pancreatic Cancers

Clinical cancer research, 2001-04, Vol.7 (4), p.812-817

2001

Link zum Volltext

Verfügbarkeit prüfen

Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care

BMC cancer, 2009-07, Vol.9 (1), p.228-228, Article 228

2009

Link zum Volltext

Verfügbarkeit prüfen

Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome

Fertility and sterility, 2010, Vol.93 (1), p.116-123

2010

Link zum Volltext

Verfügbarkeit prüfen

Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome

International journal of fertility & sterility, 2015-07, Vol.9 (2), p.157-167

2015

Link zum Volltext

Verfügbarkeit prüfen

Brustkrebsfrüherkennung

Gynäkologe (Berlin), 2018-05, Vol.51 (5), p.360-361

2018

Link zum Volltext

Verfügbarkeit prüfen

Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

BMC cancer, 2013-01, Vol.13 (1), p.32-32, Article 32

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(189)

Publikationsform

Artikel
(180)
Buchkapitel
(23)
Bücher
(14)
Berichte
(4)
Texte
(1)

Sprache

Englisch
(177)
Deutsch
(42)
Japanisch
(20)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial

Improved Overall Survival in Postmenopausal Women With Early Breast Cancer After Anastrozole Initiated After Treatment With Tamoxifen Compared With Continued Tamoxifen: The ARNO 95 Study

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Innovative Diagnostik zur Therapieoptimierung

Combined Surgical and Hormone Therapy for Endometriosis is the Most Effective Treatment: Prospective, Randomized, Controlled Trial

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

Immuntherapie in der gynäkologischen Onkologie

Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma

One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group

13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)

DNA-methylation profiling of fetal tissues reveals marked epigenetic differences between chorionic and amniotic samples

First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial

Precarious preoperative diagnostics and hints for the laparoscopic excision of uterine adenomatoid tumors: two exemplary cases and literature review

Integrative Medizin in der gynäkologischen Onkologie

Organ-preserving management of ovarian pregnancies by laparoscopic approach

Expression of the Tumor Suppressor Gene Maspin in Human Pancreatic Cancers

Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care

Circulating level of macrophage colony-stimulating factor can be predictive for human in vitro fertilization outcome

Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome

Brustkrebsfrüherkennung

Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Suchergebnisse filtern